Patents

US 9844557 B2: Proliposomal testosterone formulations

Granted
2017-12-19
Filed
2016-09-19 application 15268917
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder dispersions of the invention may be formulated with pharmaceutically acceptable excipients to form pharmaceutical compositions. Enterically coated oral dosage forms are disclosed as are methods of treatment for testosterone replacement therapy.

Source: PVGPATDIS, file of 2026-04-10 (ipg171219.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
WESTERN UNIVERSITY OF HEALTH SCIENCES 19 patentsUS company or organizationPomona, CAWESTERN UNIVERSITY OF HEALTH SCIENCES State business registration EXACT high confidence: identical full name and state
Western University of Health Sciences College or university EXACT high confidence: identical full name and state
WESTERN UNIVERSITY OF HEALTH SCIENCES Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10
TESORX PHARMA, LLC 5 patentsUS company or organizationPomona, CATesoRx Pharma, LLC Form D issuer EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Guru V. BetageriChino Hills, CA9PVGPATDIS, file of 2026-04-10
Ramachandran ThirucoteAtherton, CA9PVGPATDIS, file of 2026-04-10
Veeran Gowda KadajjiBurbank, CA5PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/568PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/16PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-11-29Assignment
Assignment of assignor's interest
THIRUCOTE, RAMACHANDRAN signed 2014-01-15TESORX PHARMA, LLC. MENLO PARK, CA40453/782ECORSEXC, file of 2026-09-25
2016-11-29Assignment
Assignment of assignor's interest
BETAGERI, GURU V. signed 2014-01-08
KADAJJI, VEERAN GOWDA signed 2014-01-08
WESTERN UNIVERSITY OF HEALTH SCIENCES POMONA, CA40453/731ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.